Women's Health

Publications

click to view chapters and sections

Disease Control Priorities in Developing Countries (2nd Edition)

1. 25. Acute Respiratory Infections in Children
   1. Interventions
2. 43. Air and Water Pollution: Burden and Strategies for Control
3. 47. Alcohol
   1. Epidemiology of Alcohol Use and Alcohol-Related Disease Conditions
4. 33. Cardiovascular Disease
5. 56. Community Health and Nutrition Programs
   1. Community-Based Programs—What Are They?
   2. Contextual Factors
   3. Programmatic Factors
6. 57. Contraception
   1. Intervention Cost and Cost-Effectiveness
   2. Interventions
   3. Nature, Causes, and Burden of the Conditions That Can Be Addressed
   4. Research and Development Agenda
7. 62. Control and Eradication
8. 15. Cost–Effectiveness Analysis for Priority Setting
   1. Definition and Characteristics of Interventions
9. 51. Cost–Effectiveness of Interventions for Musculoskeletal Conditions
   1. Economic Issues
10. 30. Diabetes: The Pandemic and Potential Solutions
    1. Cost-Effectiveness of Interventions and Priorities
11. 19. Diarrheal Diseases
    1. Preventive Strategies
    2. Public Health Significance of Diarrheal Illnesses
12. 36. Diseases of the Kidney and the Urinary System
    1. Causes of Diseases of the Kidney and Urinary System
13. 68. Emergency Medical Services
    1. Definitions
    2. Interventions for Emergency Care: Systems, Structures, and Organization
14. 11. Fiscal Policies for Health Promotion and Disease Prevention
15. 10. Gender Differentials in Health
    1. Antecedents
    2. Conclusions
    3. Cost-Effectiveness of Interventions
    4. Gender Differentials in Disease Burdens
    5. Priority Disease Groups for Women
    6. Research Agenda
    7. Women's Excess Disease Burdens
16. 64. General Primary Care
17. 29. Health Service Interventions for Cancer Control in Developing Countries
    1. Cost-Effectiveness of Cancer Control Interventions
18. 71. Health Workers: Building and Motivating the Workforce
19. 24. Helminth Infections: Soil–Transmitted Helminth Infections and Schistosomiasis
    1. Causes and Characteristics of Helminth Infections
    2. Cost-Effectiveness Analysis of Interventions
20. 18. HIV/AIDS Prevention and Treatment
    1. Action under Uncertainty
    2. Care and Treatment
    3. Prevention in Theory and Practice: Using Epidemic Profiles and Contextual Factors to Inform Prevention Guidelines
21. 48. Illicit Opiate Abuse
    1. Annex 48.A: Prevalence of Use, Adverse Health Effects of and Interventions for Cannabis, Cocaine, Amphetamines, and MDMA Use and Dependence
22. 8. Improving the Health of Populations: Lessons of Experience
    1. Cases
    2. General Findings
    3. Intervention Type, Programmatic Characteristics, and Policies
23. 42. Indoor Air Pollution
    1. Intervention Costs and Effectiveness
    2. Nature, Causes, and Burden of Condition
24. 34. Inherited Disorders of Hemoglobin
    1. Burden of Disease
    2. Control and Treatment
    3. Options for Control and Management of Inherited Hemoglobin Disorders
25. 40. Interpersonal Violence
    1. Cost-Effectiveness of Interventions
    2. Economic Impact of Violence
    3. Interventions
    4. The Nature, Burden, and Causes of Interpersonal Violence
26. 2. Intervention Cost–Effectiveness: Overview of Main Messages
    1. Assessing the Evidence on the Cost-Effectiveness of Interventions
27. 1. Investing in Health
    1. Child Health
    2. Conclusions
28. 50. Loss of Vision and Hearing
    1. Nature, Causes, and Epidemiology of Vision Loss
29. 26. Maternal and Perinatal Conditions
    1. Annex 26.A: CEA Model Assumptions
    2. Conclusions
    3. Cost-Effectiveness of Selected Intervention Packages
    4. Economic Benefits of Intervention
    5. Epidemiology of Maternal and Perinatal Conditions
    6. Interventions
    7. Lessons for Implementation
    8. Research and Development Needs
30. 31. Mental Disorders
31. 9. Millennium Development Goals for Health: What Will It Take to Accelerate Progress?
    1. Scaling Up: Defining Interventions and Removing Constraints
    2. The Millennium Development Goals for Health: Progress and Prospects
    3. What Do Countries Need To Do?
32. 32. Neurological Disorders
    1. AD and Other Dementias
    2. Stroke
33. 27. Newborn Survival
    1. Implementation
    2. Interventions
    3. Marginal Impact and Cost of Scaling Up Universal Neonatal Packages
    4. Neonatal Deaths
34. 44. Prevention of Chronic Disease by Means of Diet and Lifestyle Changes
    1. Chronic Disease Prevention
35. 4. Priorities for Global Research and Development of Interventions
36. 13. Recent Trends and Innovations in Development Assistance for Health
    1. Recent Innovations to Improve the Effectiveness of Development Assistance for Health
    2. Trends and Gaps in Development Assistance for Health
37. 58. School–Based Health and Nutrition Programs
    1. Interventions
38. 5. Science and Technology for Disease Control: Past, Present, and Future
    1. Science, Technology, and Medicine in the 20th Century
    2. Science, Technology, and Medicine in the Future
39. 17. Sexually Transmitted Infections
    1. Bacterial and Viral STIs and Their Sequelae
    2. Effectiveness of the Principal Interventions
    3. Introduction
    4. Scaling Up Control Strategies
40. 28. Stunting, Wasting, and Micronutrient Deficiency Disorders
    1. Interventions
41. 65. The District Hospital
42. 46. Tobacco Addiction
    1. Health Consequences of Smoking
43. 16. Tuberculosis
    1. Epidemiological Burden and Trends
44. 39. Unintentional Injuries
    1. Burden and Causes of Unintentional Injuries
45. 20. Vaccine–Preventable Diseases
    1. Causes and Epidemiology of Diseases Prevented by Vaccines Used in National Immunization Programs
46. 41. Water Supply, Sanitation, and Hygiene Promotion
    1. Excreta Disposal
    2. Hygiene Promotion
    3. Water Supply

Global Burden of Disease and Risk Factors

1. 4. Comparative Quantification of Mortality and Burden of Disease Attributable to Selected Risk Factors
   1. Burden of Disease Attributable to Individual Risk Factors
2. 6. Incorporating Deaths Near the Time of Birth into Estimates of the Global Burden of Disease

Priorities in Health

1. 1. Accomplishments, Challenges, and Priorities
   1. Accounting for Health Gains
   2. Equity
2. 5. Cost–Effective Strategies for Noncommunicable Diseases, Risk Factors, and Behaviors
   1. Congenital and Developmental Disorders
3. 4. Cost–Effective Strategies for the Excess Burden of Disease in Developing Countries
   1. Infectious and Communicable Diseases
   2. Maternal and Neonatal Health
4. 2. Success in Addressing Priorities
   1. Cost-Effective Interventions Aimed at Building Health Systems
   2. Cost-Effective Interventions Beyond Health Systems

Chapter Presentations

Chapter 10. Gender Differentials in Health

1. Gender Ratio of Conditions that Affect Women Disproportionately, 2001
2. Percentage of DALYs Resulting from Selected Conditions Specific to Women, 2001
3. Burden of Disease, By Gender and Age, 2001
4. Burden of Disease, By Gender and Region, 2001
5. Gender Ratio of Conditions that Affect Women Disproportionately, 2001
6. Cost-effectiveness of Selected Interventions for Maternal Conditions
7. Cost-effectiveness of Selected Interventions for Chlamydia Infection
8. Cost-effectiveness of Selected Interventions for Cervical Cancer

Chapter 59. Adolescent Health Programs

1. Worldwide Distribution of DALYs Lost Among Young Women, By Age Group, 2002
2. Young Women Ages 20-24 Who Had a Child Before Age 18, By Region

Chapter 57. Contraception

1. Average Cost of Family Planning Services per Infant and Maternal Death Averted
2. Total Potential Demand for Family Planning in Selected Countries
3. Average Cost of Family Planning Services per Birth Averted and per DALY Averted
4. Maternal Burden of Disease Associated with Unwanted Pregnancy and Unsafe Abortion